American Cancer Society Awards $2M for Diverse Cancer Research.
“Aram Hezel, M.D., associate professor of Hematology/Oncology and vice chief of the division of Hematology/Oncology at the James P. Wilmot Cancer Center at URMC, is the leader of the second four-year project.
He received $720,000 to use a recently developed mouse model as a tool to further investigate Intrahepatic Cholangiocarcinoma (IHCC), a primary cancer of the liver with poor outcomes. Using the model and samples of liver tumors from patients, Hezel’s research team is studying two important and poorly understood aspects of this disease:
1) The early stages of this cancer type, which they hope will lead to an early detection plan;
2) The energy and recycling pathways activated in IHCC tumors and other cancers, which could eventually lead to promising new treatments.”
http://www.urmc.rochester.edu/news/story/index.cfm?id=3867